Mark A. Goldsmith, See Remarks at Revolution Medicines, Inc. (RVMD), sold 30,000 shares at $50.36 ($1.5M) on 2024-10-11, disclosed to the SEC on 2024-10-15.
Scheduled sale ($1.5M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RVMD | SELL | 2026-06-18 | $1.6M | — | Filing → |
| RVMD | SELL | 2026-04-17 | $18.0M | — | Filing → |
| RVMD | SELL | 2026-03-19 | $2.6M | — | Filing → |